Exane Derivatives’s Karuna Therapeutics KRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$93.6K Hold
740
– – 0.05% 270
2022
Q1
$93.8K Sell
740
-63
-8% -$7.09K 0.03% 482
2021
Q4
$105K Buy
+803
New +$104K 0.03% 436

Other funds holding KRTX

Exane Derivatives's KRTX Position: Q2 2022 in Review

Exane Derivatives held its Karuna Therapeutics (KRTX) position steady in Q2 2022 at 740 shares worth $93.6K. The position accounts for 0.05% of the portfolio, ranked #270.

Exane Derivatives first reported a position in KRTX in Q4 2021 and has held it in 3 quarters since. The position peaked at $105K in Q4 2021. 195 funds tracked by Wall St. Rank hold KRTX as of Q2 2022.

  • Exane Derivatives held 740 shares of Karuna Therapeutics worth $93.6K as of Q2 2022.
  • Exane Derivatives left its Karuna Therapeutics share count unchanged in Q2 2022.
  • Karuna Therapeutics made up 0.05% of Exane Derivatives's portfolio in Q2 2022, its #270 holding.
  • Exane Derivatives first reported a position in Karuna Therapeutics in Q4 2021 and has held it in 3 quarters since.
  • Exane Derivatives's Karuna Therapeutics position peaked at $105K in Q4 2021.
  • 195 funds tracked by Wall St. Rank held Karuna Therapeutics as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.